Slovakia Softens Stance on CBD Regulation

September 12, 2019 15:00:21

Slovakia seems to have loosened its strict control of CBD after removing the cannabis compound from the list of controlled psychotropic ingredients. In effect, this change means that CBD will no longer be regulated in this European country.

The decision is contained in an amended bill that was passed by the country’s parliament on August 21. This decision brings the country in line with most EU countries that allow the sale of CBD tinctures, tablets and oils.

The draft bill has documents stating that since CBD doesn’t have any psychotropic properties, it is no longer necessary to list it among psychotropic ingredients. The documents also states that CBD has no potential to be addictive or to be abused by its users.

If this change is implemented, it will bring an end to the restriction which was placed on the ingredient by a 2011 law that listed the compound in Group 2 of the substances listed in the Psychotropic Substances Act.

Under that Act, the handling, importation and export of CBD products from Slovakia required one to get a permit from Ministry of Health.

The decision to include CBD on the list of controlled ingredients in 2011 was made on the basis that there was a drug (Sativex) which contained both THC and CBD. The lawmakers said that they were unaware that the drug also had CBD in it at the time they passed the 2011 law, but they didn’t take any steps to amend the law in order to remove CBD from that list.

The draft legislation has now been sent to the government for consideration and approval. Once the government approves the bill, then the law will be returned to parliament for entry into the parliamentary record.

However, the passing of that bill may not mean that industry players will have unbridled liberty to engage in the production of various CBD products and sell them on the market. As has been the case in other jurisdictions, such as the UK, separate regulations will be made sooner rather than later to set parameters for industry actors.

Coming up with such a regulatory framework has caused authorities in different countries, such as Canada, the U.S. and the UK a lot of headache since it is complex to permit an ingredient to be used in food when that ingredient has already been licensed as a pharmaceutical ingredient.

For now, experts think industry participants like Earth Science Tech Inc. (OTCQB: ETST) and Geyser Brands Inc. (TSX.V: GYSR) can celebrate the easing of restrictions on CBD in more countries across the world.

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com